Jane Street’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $155M | Buy |
285,926
+283,167
| +10,263% | +$159M | 0.01% | 701 |
|
|
2026
Q1 | $1.64M | Sell |
2,759
-214,061
| -99% | -$107M | ﹤0.01% | 5466 |
|
|
2025
Q4 | $106M | Buy |
216,820
+169,644
| +360% | +$79M | 0.02% | 558 |
|
|
2025
Q3 | $19.8M | Buy |
47,176
+18,496
| +64% | +$6.22M | ﹤0.01% | 1674 |
|
|
2025
Q2 | $8.24M | Buy |
28,680
+10,334
| +56% | +$3.09M | ﹤0.01% | 2377 |
|
|
2025
Q1 | $5.66M | Sell |
18,346
-25,147
| -58% | -$8.62M | ﹤0.01% | 2753 |
|
|
2024
Q4 | $15.3M | Buy |
43,493
+39,147
| +901% | +$14.4M | ﹤0.01% | 1485 |
|
|
2024
Q3 | $1.56M | Sell |
4,346
-12,696
| -74% | -$4.29M | ﹤0.01% | 4980 |
|
|
2024
Q2 | $5.43M | Sell |
17,042
-18,809
| -52% | -$4.98M | ﹤0.01% | 2853 |
|
|
2024
Q1 | $8.24M | Sell |
35,851
-11,602
| -24% | -$2.62M | ﹤0.01% | 2016 |
|
|
2023
Q4 | $10.4M | Buy |
47,453
+27,936
| +143% | +$6.44M | ﹤0.01% | 1899 |
|
|
2023
Q3 | $4.41M | Buy |
19,517
+1,681
| +9% | +$387K | ﹤0.01% | 2782 |
|
|
2023
Q2 | $3.94M | Buy |
17,836
+3,227
| +22% | +$715K | ﹤0.01% | 3083 |
|
|
2023
Q1 | $3.27M | Sell |
14,609
-102,446
| -88% | -$25.3M | ﹤0.01% | 3025 |
|
|
2022
Q4 | $32.6M | Buy |
117,055
+101,136
| +635% | +$25.5M | 0.02% | 721 |
|
|
2022
Q3 | $3.33M | Buy |
15,919
+14,440
| +976% | +$3.23M | ﹤0.01% | 3287 |
|
|
2022
Q2 | $349K | Sell |
1,479
-1,198
| -45% | -$244K | ﹤0.01% | 7356 |
|
|
2022
Q1 | $480K | Buy |
2,677
+428
| +19% | +$81.5K | ﹤0.01% | 7570 |
|
|
2021
Q4 | $486K | Sell |
2,249
-28,915
| -93% | -$5.68M | ﹤0.01% | 7321 |
|
|
2021
Q3 | $5.75M | Buy |
31,164
+27,222
| +691% | +$5.36M | ﹤0.01% | 2516 |
|
|
2021
Q2 | $707K | Sell |
3,942
-6,884
| -64% | -$1.31M | ﹤0.01% | 6573 |
|
|
2021
Q1 | $1.81M | Sell |
10,826
-3,362
| -24% | -$561K | ﹤0.01% | 4200 |
|
|
2020
Q4 | $2.15M | Sell |
14,188
-139
| -1% | -$18.2K | ﹤0.01% | 3358 |
|
|
2020
Q3 | $1.45M | Sell |
14,327
-92
| -0.6% | -$10.1K | ﹤0.01% | 3516 |
|
|
2020
Q2 | $1.75M | Buy |
+14,419
| New | +$1.62M | ﹤0.01% | 3253 |
|
|
2019
Q4 | – | Sell |
-4,943
| Closed | -$394K | – | 5793 |
|
|
2019
Q3 | $394K | Sell |
4,943
-769
| -13% | -$61.9K | ﹤0.01% | 3836 |
|
|
2019
Q2 | $446K | Buy |
5,712
+13
| +0.2% | +$1.22K | ﹤0.01% | 3733 |
|
|
2019
Q1 | $669K | Buy |
5,699
+2,193
| +63% | +$256K | ﹤0.01% | 3310 |
|
|
2018
Q4 | $382K | Sell |
3,506
-13,285
| -79% | -$1.54M | ﹤0.01% | 3780 |
|
|
2018
Q3 | $2.15M | Buy |
+16,791
| New | +$2.08M | ﹤0.01% | 1824 |
|
|
2018
Q1 | – | Sell |
-1,462
| Closed | -$216K | – | 5445 |
|
|
2017
Q4 | $216K | Sell |
1,462
-1,064
| -42% | -$135K | ﹤0.01% | 4127 |
|
|
2017
Q3 | $296K | Sell |
2,526
-11,436
| -82% | -$1.46M | ﹤0.01% | 3705 |
|
|
2017
Q2 | $1.81M | Buy |
+13,962
| New | +$1.74M | 0.01% | 1591 |
|
|
2017
Q1 | – | Sell |
-8,886
| Closed | -$1.27M | – | 4719 |
|
|
2016
Q4 | $1.27M | Buy |
8,886
+443
| +5% | +$56.6K | 0.01% | 1779 |
|
|
2016
Q3 | $997K | Sell |
8,443
-7,174
| -46% | -$862K | ﹤0.01% | 1967 |
|
|
2016
Q2 | $1.65M | Buy |
15,617
+8,961
| +135% | +$1,000K | 0.01% | 1470 |
|
|
2016
Q1 | $742K | Sell |
6,656
-21,866
| -77% | -$2.77M | ﹤0.01% | 2156 |
|
|
2015
Q4 | $4.47M | Buy |
28,522
+4,237
| +17% | +$617K | 0.03% | 555 |
|
|
2015
Q3 | $3.19M | Buy |
24,285
+19,985
| +465% | +$3.21M | 0.02% | 665 |
|
|
2015
Q2 | $748K | Buy |
+4,300
| New | +$774K | ﹤0.01% | 1866 |
|
|
2014
Q3 | – | Sell |
-2,354
| Closed | -$208K | – | 3086 |
|
|
2014
Q2 | $208K | Sell |
2,354
-3,692
| -61% | -$355K | ﹤0.01% | 2166 |
|
|
2014
Q1 | $569K | Buy |
+6,046
| New | +$618K | 0.01% | 1442 |
|
|
2013
Q4 | – | Sell |
-19,388
| Closed | -$1.53M | – | 2924 |
|
|
2013
Q3 | $1.53M | Buy |
+19,388
| New | +$1.42M | 0.02% | 742 |
|
Other funds holding UTHR
ACA
JT
Jane Street's UTHR Position: Q2 2026 in Review
Jane Street increased its United Therapeutics (UTHR) stake by 10,263% in Q2 2026, buying an estimated $159M and bringing the position to 285,926 shares worth $155M. The position accounts for 0.01% of the portfolio, ranked #701.
Jane Street first reported a position in UTHR in Q3 2013 and has held it in 43 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Jane Street held 285,926 shares of United Therapeutics worth $155M as of Q2 2026.
- Jane Street bought 283,167 United Therapeutics shares in Q2 2026, an estimated $159M.
- United Therapeutics made up 0.01% of Jane Street's portfolio in Q2 2026, its #701 holding.
- Jane Street first reported a position in United Therapeutics in Q3 2013 and has held it in 43 quarters since.
- 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.